U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K [ ] Form 20-F [ ] 11-K [X] Form 10-Q [ ] Form N-SAR
For Period Ended: July 31, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ______________________________________
__________________________________________________________________________
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
__________________________________________________________________________
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates: _________________
_________________________________________________________________________
_________________________________________________________________________
Part I - Registrant Information Part I - Registrant Information
___________________________________________________________________________
Full Name of Registrant: Biosynergy, Inc.
Former Name if Applicable: Not Applicable
Address of Principal Executive Office (Street and Number): 1940 E.
Devon Avenue, Elk Grove Village, Illinois 60007
__________________________________________________________________________
Part II - Rules 12b-25 (b) and (c) Part II - Rules 12b-25 (b) and (c)
___________________________________________________________________________
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate) [X] Yes [ ] No
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual, transition report on Form
10-K; Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-
25(c) has been attached if applicable.
Federal Securities Laws Section 33,321
<PAGE>
Part III - Narrative Part III - Narrative
___________________________________________________________________________
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-
Q, N-SAR or the transition report or portion thereof could not be filed
within the prescribed time period.
The finance manager for the registrant is also the production manager. As
a result of a problem with production, an entire lot of product was
rejected and had to be remanufactured to supply customers. As a result,
the financial information necessary for the Form 10Q was not able to be
prepared without unreasonable effort and expense.
Part IV - Other Information Part IV - Other Information
___________________________________________________________________________
(1) Name and telephone number of person to contract in regard to this
notification Lauane C. Addis (312) 236-4111
_____________________________________________________________
(Name) (Area Code) (Telephone No.)
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion
thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Biosynergy, Inc.
___________________________________________________________________________
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date September 11, 1997 By:
____________________________ ____________________________________
Lauane C. Addis, Secretary
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of
the representative's authority to sign on behalf of the registrant shall be
filed with the form.
___________________________________________________________________________
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
<PAGE>
